Acetylsalicyclic acid-containing transdermal application system

Details Acetylsalicyclic acid-containing transdermal application system Acetylsalicyclic acid-containing transdermal application system

1994-03-22

1999-01-19

Brouillette, D. Gabrielle

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Web, sheet or filament bases; compositions of bandages; or...

424449, A61F 1302

Patent

active

058611703

ABSTRACT:
A transdermal therapeutic system for antithrombotic therapy is disclosed. The system comprises a hydrophobic polymer matrix, acetic anhydride, and acetylsalicylic acid as the only active ingredient.

REFERENCES:
patent: 3598122 (1971-08-01), Zaffaroni
patent: 3742951 (1973-07-01), Zaffaroni
patent: 3797494 (1974-03-01), Zaffaroni
patent: 3996934 (1976-12-01), Zaffaroni
patent: 4012508 (1977-03-01), Burton
patent: 4219548 (1980-08-01), Reller
patent: 4460368 (1984-07-01), Allison
patent: 4640689 (1987-02-01), Sibalis
patent: 4665063 (1987-05-01), Bar-Shalom
patent: 4810699 (1989-03-01), Sabatucci et al.
patent: 4975269 (1990-12-01), Chavkin et al.
The Pharmacological Basis of Therapeutics, Gilman, Goodman and Gilman, Ed's pp. 1360-1361, 1980.
Fuster et al, New England Journ. of Medicine 321, 183-185 (1989); "Aspirin in the Prevention of Coronary Disease".
Buchanan et al, "Aspirin inhibits platelet function . . . " Thrombosis Research 25, 363-373 (1982).
Levy, "Clinical Pharmacokinetics of Aspirin", Pediatrics 62, 867=872 (1978).
Rowland et al, "Kinetics of Acetylsalicylic Acid Disposition in Man", Nature 215, 413-414 (1967).

Affiliated with

Also associated with

Rating

Acetylsalicyclic acid-containing transdermal application system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acetylsalicyclic acid-containing transdermal application system , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylsalicyclic acid-containing transdermal application system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1245071